Hedge Fund - Great Point Partners
Ultragenyx Pharmaceutical Inc. (RARE)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $6,900,000 | 2.24% | 300,000 | $32.89 |
| 2 | 2024 - Q1 (2024-03-31) | $0 | 0% | 0 | $47.17 |
| 3 | 2023 - Q4 (2023-12-31) | $30,987,360 | 5.28% | 648,000 | $38.77 |
| 4 | 2023 - Q3 (2023-09-30) | $25,932,737 | 4.72% | 727,426 | $39.62 |
| 5 | 2023 - Q2 (2023-06-30) | $31,249,661 | 6.11% | 677,426 | $46.38 |
| 6 | 2023 - Q1 (2023-03-31) | $27,164,783 | 5.33% | 677,426 | $42.91 |
| 7 | 2022 - Q4 (2022-12-31) | $15,858,759 | 3.1% | 342,300 | $39.33 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center